Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor Ratification

Twist Bioscience logo Key Points All three director nominees—Keith Crandell, Jan Johannessen and Trynka Shineman Blake—were duly elected; the non‑binding advisory vote approving executive compensation was approved, and stockholders ratified Ernst & Young LLP as auditor for fiscal 2026. Proxies representing 56,260,506 shares (about 91.81%) were received, constituting a quorum with a record date of December 26, 2025, and a full vote tally will be filed on Form 8‑K within four business days. The annual ...